戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 Disease: Peterax and Diamicron MR Controlled Evaluation).
2  Flow Reserve or Angiography for Multivessel Evaluation).
3 VU0424238), a compound selected for clinical evaluation.
4 od marked by heightened attunement to social evaluation.
5 nt-related potentials associated with motion evaluation.
6 ding in turn to an acute need for novel test evaluation.
7 MR imaging ex vivo and subsequent histologic evaluation.
8 ps for implantation of one of the IOLs under evaluation.
9 uld represent predictive biomarkers for risk evaluation.
10 eening of the abstracts and 93 for full text evaluation.
11 nd helping stratify patients using biomarker evaluation.
12 residence during the year prior to pulmonary evaluation.
13 the home medication list of the preoperative evaluation.
14 ctors cannot be excluded and require further evaluation.
15 as no different between groups at the 5-year evaluation.
16 e for segmenting all cells in the supervised evaluation.
17 ectiveness of these approaches needs further evaluation.
18 he week, month, and 12 mo prior to pulmonary evaluation.
19 ify suitable candidates for in vivo efficacy evaluation.
20 r syllables, suggesting a process of outcome evaluation.
21 a dermatological inspection and histological evaluation.
22 predictor of long-term outcome merit further evaluation.
23 validated by functional electrophysiological evaluation.
24 lable therapy and require further diagnostic evaluation.
25 ng services require long-term monitoring and evaluation.
26 al Skills Programme tool for health economic evaluations.
27 st method for both individual and sequential evaluations.
28 ients, when performing anti-biofilm efficacy evaluations.
29 nation every 6 months, as well as endoscopic evaluations.
30                               After detailed evaluation, 17 papers were finally selected.
31                                      At last evaluation, 277 patients (91%) are alive at 62+/-13 year
32 the Appraisal of Guidelines for Research and Evaluation, 2nd edition (AGREE II), instrument.
33 rdize murine OCT, which will facilitate data evaluation across different laboratories.
34 and seven articles were selected for further evaluation after abstracts and the full text of eligible
35 ties of chlorolissoclimide (CL) to permit an evaluation against the National Cancer Institute's 60-ce
36 erpreted as being RW-ROP positive on imaging evaluation agreed with examination findings when the exa
37                                         This evaluation aimed to investigate the clinical impact of a
38 e treating ED physician or a standard trauma evaluation alone.
39                                          The evaluation also provides the sampling precision, defined
40  Using data from the TREAT-AF (Retrospective Evaluation and Assessment of Therapies in AF) study from
41  uncovered here should be considered for the evaluation and design of clinical trials of curcumin and
42 rigin but unresolved diagnosis after medical evaluation and Fanconi anemia exclusion.
43 nic airways disease, adding impetus to their evaluation and management in difficult asthma.
44                             Individual model evaluation and multimodel comparisons with data have lar
45 h increased disease severity by histological evaluation and paw swelling compared with GFP gene trans
46 perparathyroidism do not undergo appropriate evaluation and surgical referral.
47 nd addressing the value framework of genetic evaluation and testing men at risk for PCA-a clinically
48 The patients were 3 women seeking diagnostic evaluation and therapeutic options for nonhealing facial
49 es with DR to an ophthalmologist for further evaluation and treatment would aid in reducing the rate
50 e referred to an ophthalmologist for further evaluation and treatment.
51                            Neuropathological evaluations and retrospective telephone clinical assessm
52 istopathological changes by semiquantitative evaluation, and cytokines by Luminex assay.
53 provements and debate in study design, model evaluation, and methods are still needed to mature this
54 National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7).
55 w will give an overview of the presentation, evaluation, and treatment of immunocompetent patients wi
56 ble age, Acute Physiology and Chronic Health Evaluation (APACHE) II score, severity of sepsis and ren
57 ecommendations, Assessment, Development, and Evaluation approach and summarized the results in eviden
58 f Recommendation Assessment, Development and Evaluation approach was used to make strong or weak reco
59  Recommendations Assessment, Development and Evaluation approach.
60 ecommendations, Assessment, Development, and Evaluation) approach.
61              Phase II studies with biomarker evaluation are ongoing.
62 and that KDU731 warrants further preclinical evaluation as a drug candidate for the treatment of cryp
63 ,2,4-benzothiadiazine 1,1-dioxides and their evaluation as AMPA receptor positive allosteric modulato
64 enterprise, selection of results for further evaluation based on null hypothesis significance testing
65 ered to detect genome-wide significance, the evaluation being limited to a single cortical region for
66 eliable methodology for green coffee quality evaluation, but faces barriers when applied to commercia
67 ined with a confidential, anonymous feedback evaluation by peers and coworkers regarding wellness and
68       This may aid clinicians in presurgical evaluation by providing a tool to explore various surgic
69 ty data were considered to be priorities for evaluation by the World Health Organization.
70 QoL and (4) the Center for Adherence Support Evaluation (CASE) Index, alongside the background data s
71      As physicians age, a required cognitive evaluation combined with a confidential, anonymous feedb
72 55-0.92) were less likely to complete the KT evaluation compared with white Canadians, and this assoc
73 w Reserve Versus Angiography for Multivessel Evaluation) compared PCI guided by fractional flow reser
74 an World Health Organization (WHO), Response Evaluation Criteria in Solid Tumors (RECIST), modified R
75 nfirmed objective response rate per Response Evaluation Criteria in Solid Tumors version 1.1 (central
76  phase and objective response rate (Response Evaluation Criteria In Solid Tumors version 1.1) for the
77 s of 0-1, and measurable disease by Response Evaluation Criteria in Solid Tumors version 1.1.
78 nt sunitinib dosing continued until Response Evaluation Criteria in Solid Tumors-defined disease prog
79 D, EMBASE, Cochrane Library and NHS Economic Evaluation Database, were searched for relevant studies.
80                         This multilaboratory evaluation demonstrated the novel LFD's potential utilit
81  the topic of numerous clinical and economic evaluations during the past 30 years.
82 ponin testing into a clinical risk model for evaluation emergency department patients with possible a
83 tice guidelines empirically recommend serial evaluations every 6 to 12 months.
84                                   An in vivo evaluation evidenced that trans-(+)-1d, in contrast to t
85 y testing was included in the posttransplant evaluation for 70 kidney recipients.
86 rinurad (RDEA3170), which is currently under evaluation for gout therapy.
87 lish a current average radiation dose for CT evaluation for kidney stones by querying a national dose
88 d glutamine (Gln) and arterial spin labeling evaluation for rCBF.
89 ary consensus statement to address a genetic evaluation framework for inherited PCA in the multigene
90       Teledermatology reduced median time to evaluation from 70.0 days (interquartile range [IQR], 33
91 tion Consortium, and the Journal of Research Evaluation from inception until May 2017 for publication
92 included Acute Physiology and Chronic Health Evaluation II (relative risk = 1.05 [1.02-1.09]; p = 0.0
93  APACHE [Acute Physiology and Chronic Health Evaluation] II score, 18.9).
94 d higher Acute Physiology and Chronic Health Evaluation III scores (49.2 vs 53.2 vs 68.6; p < 0.01).
95 ment for Acute Physiology and Chronic Health Evaluation III, body surface area, and age, sarcopenia i
96 ients undergoing service neural autoantibody evaluation in 2015, was 0.024%, equaling amphiphysin IgG
97                    We conducted a systematic evaluation in 72 h abstinent, chronic cannabis users (N=
98 f patients, emphasizing the need for further evaluation in larger series and close collaboration betw
99                   The IMiD-14 model warrants evaluation in prospective studies.
100               Time to first physical therapy evaluation in the intensive care unit and the hospital,
101 nd 16 patients with BE undergoing endoscopic evaluation in the United Kingdom or Greece.
102  an important component of the preprocedural evaluation in this cohort.
103 ials of atrial fibrillation, but large-scale evaluations in clinical practice are limited.
104                                              Evaluations included the relationship between each HL me
105       Some theories propose that prospective evaluation involves a reactivation of the neural respons
106 s, specificities were lower than typical for evaluations involving mostly routine clinical isolates.
107                           A longer follow-up evaluation is required to accurately describe and assess
108 ic insight and effectively conduct numerical evaluations is critically hindered when dealing with lar
109 pretest probability of CDI based on clinical evaluation, laboratory, and imaging results.
110 ies of the cancer secretome, as its clinical evaluation may change the therapeutic landscape.
111                                  At the last evaluation (median 50.0 months [IQR 27.0-78.4]), 189 (51
112 Recommendations Assessment, Development, and Evaluation) method.
113  Recommendations Assessment, Development and Evaluation) method.
114 werful, evolving tool for identification and evaluation myelin deficit in preclinical animals and pot
115    However, most conventional nondestructive evaluation (NDE) methods are based on single modality se
116 atitis (HSK group) that was quiescent during evaluation (no acute episode in the past 3 months) and 6
117 nthesis, structure, and electrophysiological evaluation of 1-ethyl-4-phenylthiomorpholin-1-ium trifla
118 domized noncomparative design allowed safety evaluation of 2 interventions concurrently in the same p
119                              A retrospective evaluation of 207 consecutive patients (131 men, 76 wome
120        In this report, we provide a detailed evaluation of 29 individuals with RTS with respect to th
121 sponses in AML, we conducted a comprehensive evaluation of 304 inhibitors, including approved and inv
122 icroplate assay offered accurate "hands-off" evaluation of 4 or 20 samples per plate run, in the stan
123               This method was applied to the evaluation of 50 clones from five mAbs programs, allowin
124 erein, we present our design, synthesis, and evaluation of a new class of PROTAC BET degraders.
125 scribe the design, synthesis, and biological evaluation of a novel class of antifungal compounds call
126 report the design, synthesis, and biological evaluation of a novel class of cannabinergic ligands, na
127  the outpatient pediatric surgery clinic for evaluation of a possible prenatal abdominal mass.
128                           This observational evaluation of a prospectively implemented quality initia
129    We report on the synthesis and biological evaluation of a series of 1,2-diarylimidazol-4-carboxami
130                                        MS/MS evaluation of a set of randomly selected 210 metabolites
131 hrough the design, synthesis, and biological evaluation of a systematic series of analogues of the or
132 ching in primer/probe binding regions, while evaluation of a WHO international reference panel for HE
133 ill allow researchers to perform comparative evaluation of AAA using a standardised approach.
134 ceiving an AI; secondary objectives included evaluation of adverse events, changes in sexual quality
135 oxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods develope
136  We describe the development and preclinical evaluation of an attenuated recombinant human parainflue
137 ancers are encouraging and support continued evaluation of anti-EGFR antibodies in this subpopulation
138                                              Evaluation of antibacterial activity against a panel of
139 f BP response to TD from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) (50 whit
140                       This paper reports the evaluation of antioxidant potential of AhJ33 fruit waste
141 al or randomized studies of septic patients, evaluation of antipyretic treatment, mortality reported,
142  the non-invasive reference standard for the evaluation of cardiac function and viability.
143 he Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial, readers at 193
144 l (Prospective Multicenter Imaging Study for Evaluation of Chest Pain), patients with stable chest pa
145 n microbiome research and lead to a rational evaluation of clinical strategies relevant for targeted
146 ging has become an indispensable tool in the evaluation of congenital heart disease, heart failure, c
147                                    Effective evaluation of costs and benefits is a core survival capa
148 stress exposure in rodents produces abnormal evaluation of costs and benefits resembling non-optimal
149                                              Evaluation of CRPC cell lines identified resistant vs se
150  for Advanced or Metastatic Prostate Cancer: Evaluation of Drug Efficacy is a randomized controlled t
151                                     In vitro evaluation of dual lactate-glucose microbiosensor reveal
152 o retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, partici
153 present study considered the pharmacokinetic evaluation of empagliflozin after administration to Egyp
154                                   Diagnostic evaluation of eosinophilic esophagitis (EoE) remains dif
155  BMI and identification, implementation, and evaluation of evidence-based interventions to address th
156 sponse for identification, notification, and evaluation of exposed patients, and management of HCDs w
157                 The global EFFORTLESS S-ICD (Evaluation oF FactORs ImpacTing CLinical Outcome and Cos
158 ensor could be a promising tool for specific evaluation of food stuff.
159 llular processes, but tools for quantitative evaluation of GTP levels in live cells have not been ava
160  the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable t
161 tem-level interventions which prompt further evaluation of hypercalcemia and raise physician awarenes
162 s a novel and feasible method for automating evaluation of ICU patient mobility.
163 3 cells were used as cellular models for the evaluation of IDO1 expression in thyroid carcinoma cells
164 aging biomarkers for diagnosis and treatment evaluation of inflammatory arthritis.
165             OCT and OCTA images, qualitative evaluation of iris and tumor vasculature, and quantitati
166                                  The present evaluation of isoconversional activation energies afford
167 rate the potential of FIMTrack we provide an evaluation of its accuracy using manually labeled data.
168 tratigraphy, information that is crucial for evaluation of its authenticity and attribution, for insi
169                     This in turn forces a re-evaluation of its demography and extinction dynamics.
170 clusion Use of reduced-radiation dose CT for evaluation of kidney stones has increased since 2011-201
171 of reduced-dose computed tomography (CT) for evaluation of kidney stones increased in 2015-2016 compa
172 nts referred for 3-T magnetic resonance (MR) evaluation of known or suspected uterine leiomyomas.
173 MIBG) imaging is currently a mainstay in the evaluation of many neuroendocrine tumors, especially neu
174                                              Evaluation of many of the TBK1 missense mutations found
175                       Generally, the sensory evaluation of meat samples was affected the most in the
176 sample of 144 adults, enrolled in the Ginkgo Evaluation of Memory study at a university center from J
177                                              Evaluation of microcirculation perfusion is critical for
178  facilitate comparison among studies and the evaluation of multiple competing hypotheses.
179            Here we present the discovery and evaluation of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrim
180 atural understanding and better quantitative evaluation of natural cracks including stress corrosion
181 for overall survival (OS) could expedite the evaluation of new adjuvant therapies.
182 ble and frequently delayed, complicating the evaluation of new immunotherapy agents and customizing t
183 progress will require careful assessment and evaluation of new methods, force fields, and modeling in
184 re, here we report the design, synthesis and evaluation of novel GDC-0449 analogs using N-[3-(2-pyrid
185 inant analysis were used for the statistical evaluation of obtained experimental data.
186                This approach permitted rapid evaluation of over 400 admixture combinations for the ox
187 a and provide the rationale for the clinical evaluation of PAK4 modulator in myeloma.
188  MRI has moderate prognostic accuracy in the evaluation of patients with PAH.
189                                To inform the evaluation of patients with suspected botulism, we condu
190     A checklist is provided for the clinical evaluation of patients with suspected usual interstitial
191  changing PD-L1 expression and heterogeneity evaluation of PD-L1 expression across tumors in the same
192                             (Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate
193                              Included is the evaluation of porous silicon oxide present on different
194                         Indications included evaluation of post-treatment scar (55%) or fovea (16%),
195 tudy comprises a systematic and quantitative evaluation of potential intrinsic and extrinsic factors
196                                              Evaluation of predictions against corresponding experime
197            Our discovery prompts critical re-evaluation of prevailing uplift models of the plateau an
198 e newly described STAT2 KO hamster model for evaluation of promising antiviral therapies.
199                  Tools that enable the rapid evaluation of protective immune responses are essential
200 s of changes in tau burden over time for the evaluation of putative therapies.
201  scored changes in management based on early evaluation of response by (18)F-FDG PET in patients in t
202 f this system may allow noninvasive detailed evaluation of retinal vasculature during surgical proced
203    Here we describe genome-engineering based evaluation of RNA regulatory element activity (GenERA),
204 ysis of prospective data from the Randomized Evaluation of Sedation Titration for Respiratory Failure
205 ere the synthesis, assembly and cytotoxicity evaluation of self-assembling hybrid prodrugs containing
206     Our findings suggest that a more nuanced evaluation of spatial variability in climatic and biotic
207        This metric allows rapid and rigorous evaluation of specimen preparation methods, assisting st
208 hic (CT) angiography as part of the clinical evaluation of stable chest pain.
209                        However, quantitative evaluation of such feedbacks is still insufficient.
210 y definitely has a major role to play in the evaluation of suprahyoid neck masses as it has an excell
211  in cases of SADS and comprehensive clinical evaluation of surviving relatives.
212 an linezolid against NTM and suggest that an evaluation of tedizolid as a potential treatment agent f
213 hmark data sets, we carried out a systematic evaluation of ten publicly available AMP prediction meth
214 ients underwent an intensive pharmacokinetic evaluation of the concentrations of sofosbuvir, ledipasv
215                             Careful clinical evaluation of the condyle coupled with appropriate radio
216 e applied ion chromatographic method for the evaluation of the content of nitrite and nitrate in suga
217 he coronaries is a good and rapid method for evaluation of the coronary anatomy and for early detecti
218        We have put a particular focus on the evaluation of the degree of addition and the bulk functi
219 ut anti-BP180 NC16A IgG reactivity underwent evaluation of the diagnostic importance of serum anti-BP
220              Finally, the REVEAL (Randomized Evaluation of the Effects of Anacetrapib through Lipid m
221                                              Evaluation of the elasticity of the adsorbed layer confi
222                                    Long term evaluation of the electrode was found to be stable.
223                                              Evaluation of the epitope specificities, locations (syst
224                     DISCUSSION: Based on our evaluation of the evidence, we conclude that current reg
225 nstrated that the selected model allowed the evaluation of the extraction rate and extent of USC-CO2
226                                    The first evaluation of the general patient wishes for the treatme
227                                           Re-evaluation of the growth data and correction for the bia
228 I) has been used for many years for anatomic evaluation of the kidney.
229                               A quantitative evaluation of the LC-FAIMS-MS method was performed givin
230                      To conduct a systematic evaluation of the magnitude of practice effects on the M
231 tted parameter values represent experimental evaluation of the magnitudes of most physical mechanisms
232 n a clinical context by providing a critical evaluation of the prognostic and diagnostic insights tha
233                                    After the evaluation of the reactivity of the dimethyl ester deriv
234                                              Evaluation of the robustness of statistically significan
235              We completed the first clinical evaluation of the Triplex vaccine in 24 healthy adults,
236 onducted a pragmatic multicenter prospective evaluation of the use of point-of-care BLAST by ASPs.
237                                     Accurate evaluation of the volume exclusion effect is made possib
238 n set up to address this, there is a lack of evaluation of their effectiveness.
239  OAC rates in AF patients, but a large-scale evaluation of their effects has not been conducted.
240 rement to synthesis of cyclic polyethers and evaluation of their metal ion complexation properties.
241 ntification of virulence determinants or the evaluation of therapeutics, we infected them with a gree
242                          Afterwards, sensory evaluation of these products containing 10% tainted meat
243                                     Although evaluation of this hypothesis is constrained by the limi
244       Kirkpatrick's four level model for the evaluation of training interventions was adopted to stru
245 ted potentiometric immunosensor for in vitro evaluation of Trp consumption and Kyn production control
246       This report presents new spectroscopic evaluation of two Mn(II) proteins important for bacteria
247  week-long, time series enabled simultaneous evaluation of ultradian rhythms as well as fractal organ
248                              To expedite the evaluation of vaccines against paratyphoid fever, we aim
249 addition to anatomical mapping, the complete evaluation of vascular anomalies includes hemodynamic ch
250 ological information may be lost, making the evaluation of viruses obtained during acute infection, r
251                            Hence, systematic evaluation of white matter microstructure in the normati
252 ary tract infections (UTIs), yet large-scale evaluations of bacteriuria management among inpatients a
253 49 studies identified, most were preliminary evaluations of feasibility and acceptability.
254 ual clinical decisions; however, its role in evaluations of healthcare outcomes and quality has recei
255                      In serial health status evaluations of patients with HF, the most recent KCCQ sc
256 tro and in vivo observations support further evaluations of pretargeting fusion protein cocktails as
257 oped tests seem more sensitive, high-quality evaluations of these tests are lacking.
258    Complementary microbiological and imaging evaluations on both planktonic and surface-attached bact
259 ould be of great relevance to either outcome evaluation or study design.
260 s in the Acute Physiology and Chronic Health Evaluation Outcomes dataset, 80.1% were matched with dat
261 ating in Acute Physiology and Chronic Health Evaluation Outcomes.
262 ine the predictors of entering a hearing aid evaluation period (HAEP) using a prospective design draw
263 onsuming and often a major bottleneck in the evaluation pipeline.
264 gery with visual symptom scales at follow-up evaluations ranged from r = 0.24 to r = 0.49.
265 andardized group, all patients had a minimal evaluation regardless of the type of uveitis (complete b
266        The present study examines how social evaluation shapes views of the self and others different
267                            These preclinical evaluations show a high propensity of 4-(11)C-MBZA towar
268                                 Histological evaluation showed larger lumen areas and evidence of hig
269                                          Our evaluation shows that NGSCheckMate is effective for a va
270                                          Our evaluation shows that Seqping was able to generate bette
271 ave potential applications in nondestructive evaluation, spatial wave filtering, energy harvesting, a
272                     In this multi-laboratory evaluation study including 11 sites worldwide, we demons
273 t strategies have been used to perform these evaluations, such as a comparison of the total number of
274                 Experimental and statistical evaluations suggest that using ML algorithms for learnin
275                            Standard clinical evaluation suggested a diagnosis in 16% of cases (54/337
276                                         This evaluation system is set up according to ICH/GCP, World
277 lity of life using the Cancer Rehabilitation Evaluation System sexuality subscales, changes in vagina
278  Recommendations Assessment, Development and Evaluation) system.
279 lecular diagnosis after the initial genetics evaluation, that rate is much lower.
280 lled, open-label trials with blinded outcome evaluation: the POT-KAST trial, which included patients
281 ical studies have linked numerical magnitude evaluation to a wide variety of core phenomena in decisi
282 bel treatment trial with a blinded end-point evaluation to compare GA with CS for treatment of endova
283 y on preconception counseling and diagnostic evaluation to determine maternal and fetal risk but also
284 ose of this study was to perform a multisite evaluation to establish the performance characteristics
285 al-directed learning by a process of outcome evaluation to gradually select appropriate motor actions
286 portance of thorough clinical and laboratory evaluations to exclude secondary causes of disease.
287 Recommendations Assessment, Development, and Evaluation tool, the quality of evidence for mortality w
288    Agreement was similar to that of previous evaluations using the WHO methodology for detecting cons
289 hest behavioral diagnosis obtained after six evaluations) using nonparametric statistics.
290                        Median age at genetic evaluation was 11 years; 20.7% of patients were aged </=
291                  The in situ enzyme activity evaluation was based on the ability of NKA to transform
292                                         This evaluation was combined with the analysis of RANK/RANKL
293   A preimplementation and postimplementation evaluation was conducted from January 6, 2014, to Novemb
294                                      Sensory evaluation was conducted to determine the perceptible se
295 acids and texture profiles and sensory panel evaluations were considered.
296 to determine which method for early response evaluation with (18)F-FDG PET/CT performed most optimall
297 secutive patients with BP underwent clinical evaluation with the Bullous Pemphigoid Disease Activity
298          At the time of imaging, behavioural evaluation with the Coma Recovery Scale-Revised indicate
299  were randomly assigned to a standard trauma evaluation with the FAST examination by the treating ED
300 egies have advanced to the stage of clinical evaluation with unprecedented speed.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top